Radiomics for prognostication in primary sclerosing cholangitis: a proof-of-concept using GLRLM run entropy

被引：0

作者：

Cristoferi, Laura ^{[1
]}

Maino, Cesare ^{[2
]}

Bernasconi, Davide ^{[3
]}

Savino, Alberto ^{[1
,4
]}

Ripamonti, Ilaria ^{[1
,4
]}

Scaravaglio, Miki ^{[1
,4
]}

Pesatori, Eugenia Vittoria ^{[5
]}

D'Amato, Daphne ^{[6
]}

Gerussi, Alessio ^{[1
,4
]}

Alberzoni, Chiara ^{[2
]}

Valsecchi, Maria Grazie ^{[3
]}

Corso, Rocco ^{[2
]}

Ippolito, Davide ^{[2
,4
]}

Invernizzi, Pietro ^{[1
,4
]}

De Bernardi, Elisabetta ^{[4
]}

Carbone, Marco ^{[4
,7
]}

机构：

[1] Fdn IRCCS San Gerardo Tintori, European Reference Network Hepatol Dis ERN RARE L, Dept Gastroenterol & Hepatol, Monza, Italy

[2] Fdn IRCCS San Gerardo Tintori, Dept Radiol, Monza, Italy

[3] Univ Milano Bicocca, Sch Med & Surg, Bicocca Bioinformat Biostat & Bioimaging Ctr B4, Monza, Italy

[4] Univ Milano Bicocca, Monza, Italy

[5] Papa Giovanni XXIII Hosp, Hepatol & Liver Transplant Unit, Bergamo, Italy

[6] Univ Turin, Div Gastroenterol & Hepatol, Dept Med Sci, Turin, Italy

[7] ASST Grande Osped Metropolitano Niguarda, Hepatol & Gastroenterol Unit, Milan, Italy

来源：

JOURNAL OF HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-133-YI

引用

页码：S325 / S325

页数：1

共 50 条

[1] Radiomics-based prognostication in primary sclerosing cholangitis: a proof-of-concept study
Cristoferi, L.
Maino, C.
Bernasconi, D. P.
Savino, A.
Ripamonti, I.
Scaravaglio, M.
Pesatori, E.
Falco, O.
D'Amato, D.
Gerussi, A.
Gallivanone, F.
Alberzoni, C.
Valsecchi, M. G.
Corso, R.
Invernizzi, P.
Ippolito, D.
De Bernardi, E.
Carbone, M.
DIGESTIVE AND LIVER DISEASE, 2024, 56 : S11 - S11
[2] A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis
Kowdley, Kris V.
Forman, Lisa
Eksteen, Bertus
Gunn, Nadege
Sundaram, Vinay
Landis, Charles
Harrison, Stephen A.
Levy, Cynthia
Liberman, Alexander
Di Bisceglie, Adrian M.
Hirschfield, Gideon M.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (11): : 1805 - 1815
[3] SAFETY AND EFFICACY OF MARALIXIBAT IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: AN OPEN-LABEL PROOF-OF-CONCEPT STUDY
Bowlus, Christopher L.
Eksteen, Bertus
Cheung, Angela
Thorburn, Douglas
Moylan, Cynthia A.
Pockros, Paul J.
Forman, Lisa
Dorenbaum, Alejandro
Hirschfield, Gideon
Kennedy, Ciara
Gu, Joan
Apostol, George
Vig, Pamela
Levy, Cynthia
HEPATOLOGY, 2019, 70 : 764A - 765A
[4] A randomized phase II proof-of-concept study of beta-lapachone in patients with primary sclerosing cholangitis
Paik, Woo Hyun
Park, Joo Kyung
Chung, Moon Jae
Huh, Gunn
Jeong, Heon Se
Kim, Hee Jin
Park, Do Hyun
JOURNAL OF HEPATOLOGY, 2024, 80 : S323 - S323
[5] Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study
Sarah Poetter-Lang
Alina Messner
Nina Bastati
Kristina I. Ringe
Maxime Ronot
Sudhakar K. Venkatesh
Raphael Ambros
Antonia Kristic
Aida Korajac
Gregor Dovjak
Martin Zalaudek
Jacqueline. C. Hodge
Christoph Schramm
Emina Halilbasic
Michael Trauner
Ahmed Ba-Ssalamah
European Radiology, 2023, 33 : 9022 - 9037
[6] Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study
Poetter-Lang, Sarah
Messner, Alina
Bastati, Nina
Ringe, Kristina I.
Ronot, Maxime
Venkatesh, Sudhakar K.
Ambros, Raphael
Kristic, Antonia
Korajac, Aida
Dovjak, Gregor
Zalaudek, Martin
Hodge, Jacqueline. C.
Schramm, Christoph
Halilbasic, Emina
Trauner, Michael
Ba-Ssalamah, Ahmed
EUROPEAN RADIOLOGY, 2023, 33 (12) : 9022 - 9037
[7] Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis
Vuppalanchi, Raj
Caldwell, Stephen H.
Pyrsopoulos, Nikolaos
DeLemos, Andrew S.
Rossi, Simona
Levy, Cynthia
Goldberg, David S.
Mena, Edward A.
Sheikh, Aasim
Ravinuthala, Ravi
Shaikh, Farheen
Bainbridge, James D.
Parmar, Deven, V
Chalasani, Naga P.
JOURNAL OF HEPATOLOGY, 2022, 76 (01) : 75 - 85
[8] Safety and efficacy of the farnesoid X receptor (FXR) agonist cilofexor in a proof-of-concept study in patients with compensated cirrhosis due to primary sclerosing cholangitis (PSC)
Levy, Cynthia
Caldwell, Stephen
Mantry, Parvez
Luketic, Velimir
Landis, Charles
Huang, Jonathan
Mena, Edward
Maheshwari, Rahul
Rank, Kevin
Xu, Jun
Lu, Xiangyu
Lu, Xiaomin
Chung, Chuhan
Myers, Robert
Kowdley, Kris
JOURNAL OF HEPATOLOGY, 2022, 77 : S319 - S320
[9] Radiomics-based model for outcome prediction in primary sclerosing cholangitis
Cristoferi, Laura
Porta, Marco
Bernasconi, Davide
Filippo, Leonardi
Mulinacci, Giacomo
Palermo, Andrea
Gerussi, Alessio
Scaravaglio, Miki
Gallo, Camilla
Stucchi, Eliana
Maino, Cesare
Ippolito, Davide
D'Amato, Daphne
Ferreira, Carlos
Mavar-Haramija, Marija
Banerjee, Rajarshi
Antolini, Laura
Valsecchi, Maria Grazie
Fagiuoli, Stefano
Invernizzi, Pietro
Carbone, Marco
JOURNAL OF HEPATOLOGY, 2022, 77 : S96 - S96
[10] RADIOMICS-BASED MODEL FOR OUTCOME PREDICTION IN PRIMARY SCLEROSING CHOLANGITIS
Cristoferi, Laura
Porta, Marco
Bernasconi, Davide Paolo
Leonardi, Filippo
Mulinacci, Giacomo
Palermo, Andrea
Gerussi, Alessio
Gallo, Camilla
Scaravaglio, Miki
Stucchi, Eliana
Maino, Cesare
Ippolito, Davide
D'Amato, Daphne
Ferreira, Carlos
Mavar, Marija
Banerjee, Rajarshi
Antolini, Laura
Valsecchi, Maria Grazia
Fagiuoli, Stefano
Invernizzi, Pietro
Carbone, Marco
GASTROENTEROLOGY, 2022, 162 (07) : S1286 - S1287

← 1 2 3 4 5 →